These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 219700)

  • 1. Pathogenesis of reactivated latent murine cytomegalovirus infection.
    Shanley JD; Jordan MC; Cook ML; Stevens JG
    Am J Pathol; 1979 Apr; 95(1):67-80. PubMed ID: 219700
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vivo model for the acute, latent and reactivated phases of cytomegalovirus infection.
    Gönczöl E; Danczig E; Boldogh I; Tóth T; Váczi L
    Acta Microbiol Hung; 1985; 32(1):39-47. PubMed ID: 2994350
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunosuppression reactivates and disseminates latent murine cytomegalovirus.
    Jordan MC; Shanley JD; Stevens JG
    J Gen Virol; 1977 Nov; 37(2):419-23. PubMed ID: 200714
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vivo reactivation of latent murine cytomegalovirus in the eye by immunosuppressive treatment.
    Rabinovitch T; Oh JO; Minasi P
    Invest Ophthalmol Vis Sci; 1990 Apr; 31(4):657-63. PubMed ID: 2159448
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunosuppression reactivates and disseminates latent murine cytomegalovirus.
    Jordan MC; Shanley JD; Stevens JG
    IARC Sci Publ (1971); 1978; (24 Pt 2):769-74. PubMed ID: 221402
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The pathogenesis of murine cytomegalovirus ocular infection. Anterior chamber inoculation.
    Bale JF; O'Neil ME; Lyon B; Perlman S
    Invest Ophthalmol Vis Sci; 1990 Aug; 31(8):1575-81. PubMed ID: 2167300
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ocular reactivation of MCMV after immunosuppression of latently infected BALB/c mice.
    Zhang M; Xin H; Duan Y; Atherton SS
    Invest Ophthalmol Vis Sci; 2005 Jan; 46(1):252-8. PubMed ID: 15623781
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Murine cytomegalovirus is present in both chronic active and latent states in persistently infected mice.
    Yuhasz SA; Dissette VB; Cook ML; Stevens JG
    Virology; 1994 Jul; 202(1):272-80. PubMed ID: 8009839
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of temperature-sensitive mutants of mouse cytomegalovirus as vaccines.
    Sandford GR; Burns WH
    J Infect Dis; 1988 Sep; 158(3):596-601. PubMed ID: 2842407
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Investigation of murine cytomegalovirus latency and reactivation in mice using viral mutants and the polymerase chain reaction.
    Bevan IS; Sammons CC; Sweet C
    J Med Virol; 1996 Apr; 48(4):308-20. PubMed ID: 8699162
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adverse effects of cytomegalovirus vaccination in mice.
    Jordan MC
    J Clin Invest; 1980 Apr; 65(4):798-803. PubMed ID: 6244333
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Experimental murine cytomegalovirus infection in severe combined immunodeficient mice.
    Reynolds RP; Rahija RJ; Schenkman DI; Richter CB
    Lab Anim Sci; 1993 Aug; 43(4):291-5. PubMed ID: 8231084
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Murine cytomegalovirus-associated pneumonitis in the lungs free of the virus.
    Tanaka K; Koga Y; Lu YY; Zhang XY; Wang Y; Kimura G; Nomoto K
    J Clin Invest; 1994 Sep; 94(3):1019-25. PubMed ID: 8083343
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Direct evidence using in situ polymerase chain reaction that the endothelial cell and T-lymphocyte harbor latent murine cytomegalovirus.
    Koffron AJ; Mueller KH; Kaufman DB; Stuart FP; Patterson B; Abecassis MI
    Scand J Infect Dis Suppl; 1995; 99():61-2. PubMed ID: 8668944
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dissemination and replication of MCMV after supraciliary inoculation in immunosuppressed BALB/c mice.
    Duan Y; Ji Z; Atherton SS
    Invest Ophthalmol Vis Sci; 1994 Mar; 35(3):1124-31. PubMed ID: 8125723
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Murine cytomegalovirus infection model in Balb/c mice--1. Virological and pathological profiles in mice inoculated with various virus doses.
    Leung WC; Hashimoto K; Hata J
    Tokai J Exp Clin Med; 1986 Oct; 11(4):293-301. PubMed ID: 3039695
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Murine cytomegalovirus gene amplification and culture after submaxillary salivary gland biopsy.
    Schmader KE; Rahija RJ; Porter KR; Hamilton JD
    Lab Anim Sci; 1991 Oct; 41(5):396-400. PubMed ID: 1666135
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reactivation of rat cytomegalovirus in lung allografts: an experimental and immunohistochemical study in rats.
    Yagyu K; Steinhoff G; Duijvestijn AM; Bruggeman CA; Matsumoto H; van Breda Vriesman PJ
    J Heart Lung Transplant; 1992; 11(6):1031-40. PubMed ID: 1333797
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Studies of ocular murine cytomegalovirus infection.
    Hayashi K; Kurihara I; Uchida Y
    Invest Ophthalmol Vis Sci; 1985 Apr; 26(4):486-93. PubMed ID: 2984137
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Murine models of cytomegalovirus-associated pneumonitis.
    Shanley JD
    Transplant Proc; 1991 Jun; 23(3 Suppl 3):12-6, discussion 16. PubMed ID: 1648814
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.